Declaration form for inadequately labelled samples and correct labelling error in person before samples may be processed. Samples from patients Sample not processed. CSF samples The request form and sample details do not Report issued stating that Blood Culture should have corresponding details. correspond with the Different names on form samples request form. and sample(s) or Incorrect Unrepeatable PID or Name stated) samples Unlabelled / Mislabelled Sample not processed. CSF samples samples Report issued stating that Blood Culture unlabelled sample received samples Unrepeatable specimens-refer to and This sample deviated Unrepeatable sample deviation acceptance policy from Pathology Labelling samples in Introduction section of this Policy. Requesting manual. clinician was contacted by Requesting Clinician is required to the laboratory and informed complete form: PATH-GEN-FRM-3 of requirement to rectify Declaration form for inadequately labelling error and complete labelled samples and correct Declaration Form for labelling in person before Inadequately Labelled samples may be processed. Specimens. Nature of deviation stated ie Unlabelled samples or Mislabelled samples. Samples with no clinical Sample not processed. Any ICU samples Relevant clinical information is details or inappropriate samples received without NICU necessary in to allow choice of clinical details provided accompanying appropriate RDU samples relevant tests and interpretation of on request form ( clinical details will also be Haematology/ test results. including antibiotic rejected with the following Oncology assays) comment (or patients If clinical information is “No inappropriate)clinical Diabetic patients subsequently provided, this is details provided. Sample Any sample that recorded on the report and the not processed. Relevant cannot be easily sample is processed. clinical information is repeated e.g. necessary in order to allow tissue, CSF, interpretation of test results. aspirates, blood Samples will be held for 48 cultures, BALs, hours and processed if biopsies. relevant clinical details are MRSA/VRE provided” screens (including CSU urines from known MRSA carriers)
Declaration form for inadequately labelled samples and correct labelling error in person before samples may be processed. Samples from patients details do not correspond with the request form. Sample not processed. Report issued stating that Different names on form and sample(s) or Incorrect PID or Name stated) CSF samples Blood Culture samples Unrepeatable samples The request form and sample should have corresponding details. Unlabelled / Mislabelled samples Sample not processed. Report issued stating that unlabelled sample received and This sample deviated from Pathology Labelling Policy. Requesting clinician was contacted by the laboratory and informed of requirement to rectify labelling error and complete Declaration Form for Inadequately Labelled Specimens. Nature of deviation stated ie Unlabelled samples or Mislabelled samples. CSF samples Blood Culture samples Unrepeatable samples Unrepeatable specimens-refer to sample deviation acceptance policy in Introduction section of this manual. Requesting Clinician is required to complete form: PATH-GEN-FRM-3 Declaration form for inadequately labelled samples and correct labelling in person before samples may be processed. Samples with no clinical details or inappropriate clinical details provided on request form ( including antibiotic assays) Sample not processed. Any samples received without accompanying appropriate clinical details will also be rejected with the following comment “No (or inappropriate)clinical details provided. Sample not processed. Relevant clinical information is necessary in order to allow interpretation of test results. Samples will be held for 48 hours and processed if relevant clinical details are provided” ICU samples NICU RDU samples Haematology/ Oncology patients Diabetic patients Any sample that cannot be easily repeated e.g. tissue, CSF, aspirates, blood cultures, BALs, biopsies. MRSA/VRE screens (including CSU urines from known MRSA carriers) Relevant clinical information is necessary in to allow choice of relevant tests and interpretation of test results. If clinical information is subsequently provided, this is recorded on the report and the sample is processed.
pathology-user-handbook-2018-revision-12.docx